Business
SlimBiome® Medical launches in UK market
SlimBiome® Medical launches in UK market.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \nRNS Number : 8468W OptiBiotix Health PLC 24 April 2019 \n\nOptiBiotix Health plc\n(\"OptiBiotix\")\n \nSlimBiome® Medical launches in UK market\n \nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high\ncholesterol and diabetes, announces the launch of its innovative weight management solution SlimBiome® Medical to the UK market.\n \nSlimBiome® Medical, which is a CE marked medical device, offers a healthy, hunger-free weight management solution designed for use by itself, or as part of a calorie-restricted diet, to reduce hunger and help users achieve sustainable weight loss. Independent clinical studies show SlimBiome® reduces hunger, cravings for sweet and savoury foods, and fat intake. It will be available in boxes of 30 single dose sachets and for purchase from the OptiBiotix Online store (Optibiotix.online) from 29 April 2019. \n \nThis commercial launch follows on from the announcement that SlimBiome® was granted medical device status and a CE mark (RNS: 27 November 2018), the appointment of Nutrilinea S.R.L as a manufacturer (RNS: 29 November 2018), and three year distribution agreements for Greece and Cyprus (RNS: 4 December 2018) and Bulgaria (RNS: 9 April 2019).\n \nOptiBiotix is also pleased to report prelaunch sales of SlimBiome® Medical to Bridge4 Health Ltd, a unique health and well-being centre based in Leicester. Bridge4 Health will conduct a three month SlimBiome® Medical field trial involving its gym members to support healthy sustained weight loss. These early deals and sales orders so soon after achieving medical device registration reflect the high level of interest we have received in SlimBiome® Medical from an industry which recognises the value of products with strong science and published human studies.\n \nThe online sale of SlimBiome® Medical as a final product is another example of OptiBiotix's strategy of building multiple revenue streams from ingredient sales, white label and own label branded consumer products, across multiple sales channels. It provides a new route to market for SlimBiome® allowing the company to generate immediate revenues while building sales with international and retail partners f...